To Study the role of Serum Procalcitonin in determining the severity of Acute Pancreatitis
Not Applicable
- Conditions
- Health Condition 1: K85- Acute pancreatitis
- Registration Number
- CTRI/2021/06/034141
- Lead Sponsor
- Kasturba Medical college and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who fulfil the diagnostic criteria for acute pancreatitis and reporting within 48 hours of onset of initial
Exclusion Criteria
â?ª Patients with Chronic Pancreatitis, Recurrent
Pancreatitis.
â?ª Patients with severe burns or major trauma.
â?ª Patients with severe or prolonged Cardiogenic shock.
â?ª Patients with small cell lung cancer or medullary
carcinoma thyroid.
â?ª Patients with Chronic Kidney Disease.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of acute pancreatitis in relation to the procalcitonin levelsTimepoint: Serum Procalcitonin levels will be assessed in the first 24 hrs. Severity is assessed at the end of 48Hrs
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil